Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (151-160 of 205) with videos related to

Pageof 21
Sort By:
The Lancet. Gastroenterology & Hepatology|July 10, 2018
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysisEric Nguyen-Khac, Maja Thiele, Cosmin Voican, et al.
Journal of Hepatology|July 8, 2020
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis deltaDominique Roulot, Ségolène Brichler, Richard Layese, et al.
Journal of Hepatology|August 10, 2013
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinomaMarianne Ziol, Angela Sutton, Julien Calderaro, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Improving risk stratification and detection of early HCC using ultrasound-based deep learning modelsJérémy Dana, Adrien Meyer, Anita Paisant, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2026
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumabErwan Vo-Quang, Claudia Campani, Manon Allaire, et al.
JAMA|May 9, 2023
Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis: A Randomized Clinical TrialAlexandre Louvet, Julien Labreuche, Thong Dao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related MortalityCarolin V Schneider, Stefan Gross, Sriram Balasubramani, et al.
Hepatology (Baltimore, Md.)|March 26, 2019
A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver DiseaseJie Yang, Eric Trépo, Pierre Nahon, et al.
Hepatology (Baltimore, Md.)|October 12, 2013
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant dataEric Trépo, Pierre Nahon, Gianluca Bontempi, et al.
International Journal of Cancer|October 6, 2018
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseasesJie Yang, Eric Trépo, Pierre Nahon, et al.
Pageof 21

Showing results (151-160 of 205) with videos related to

Sort By:
Pageof 21
The Lancet. Gastroenterology & Hepatology|July 10, 2018
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysisEric Nguyen-Khac, Maja Thiele, Cosmin Voican, et al.
Journal of Hepatology|July 8, 2020
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis deltaDominique Roulot, Ségolène Brichler, Richard Layese, et al.
Journal of Hepatology|August 10, 2013
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinomaMarianne Ziol, Angela Sutton, Julien Calderaro, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Improving risk stratification and detection of early HCC using ultrasound-based deep learning modelsJérémy Dana, Adrien Meyer, Anita Paisant, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2026
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumabErwan Vo-Quang, Claudia Campani, Manon Allaire, et al.
JAMA|May 9, 2023
Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis: A Randomized Clinical TrialAlexandre Louvet, Julien Labreuche, Thong Dao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related MortalityCarolin V Schneider, Stefan Gross, Sriram Balasubramani, et al.
Hepatology (Baltimore, Md.)|March 26, 2019
A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver DiseaseJie Yang, Eric Trépo, Pierre Nahon, et al.
Hepatology (Baltimore, Md.)|October 12, 2013
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant dataEric Trépo, Pierre Nahon, Gianluca Bontempi, et al.
International Journal of Cancer|October 6, 2018
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseasesJie Yang, Eric Trépo, Pierre Nahon, et al.
Pageof 21